Larkberget

Larkberget P/B

The P/B (Price-to-Book Ratio) of Larkberget (LARK.ST) as of Oct 16, 2026 is 0.88. In the previous year, P/B (Price-to-Book Ratio) was 0.68 — a change of 28.99% (higher).

P/B

0.88

YoY

28.99%

Last updated:

P/B (Price-to-Book Ratio) of Larkberget is 2025 0.88 . P/B (Price-to-Book Ratio) of Larkberget was 2024 0.68 . It decreases by 28.99% higher compared to the previous year.

The Larkberget P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2018
2.38 SEK
Jan 1, 2019
2.64 SEK
Jan 1, 2020
0.68 SEK
Jan 1, 2021
0.31 SEK
Jan 1, 2022
0.32 SEK
Jan 1, 2023
0.42 SEK
Jan 1, 2024
0.68 SEK
Jan 1, 2025
0.88 SEK
The Larkberget P/B history
YEARP/BYoY
0.88+28.99%
0.68+62.70%
0.42+30.63%
0.32+4.05%
0.31-54.87%
0.68-74.15%
2.64+10.78%
2.38-68.16%
7.48-37.36%
11.94+151.64%
4.75-44.81%
8.60—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Larkberget Stock analysis

What does Larkberget do? Larkberget AB, trading under the ticker LARK.ST, is a biotechnology company based in Lidingoe, Sweden. The company, which is listed on the Stockholm Stock Exchange, went public through an IPO on May 25, 2015. Larkberget AB operates within the health care sector, specifically in the biotechnology industry. The company's website is https://combigene.com/. According to the provided information, Larkberget AB is engaged in the development of new treatments for neurological diseases. The firm's platform involves the use of gene therapy vectors to deliver combinations of transgenes encoding neuropeptide Y (NPY) receptors, galanin, galanin receptors, somatostatin, and somatostatin receptors. These vectors are designed for the treatment of neurological and psychiatric diseases in both humans and animals. The company focuses on developing an epilepsy treatment using an adeno-associated virus (AAV) vector that carries transgenes for the neurotransmitter NPY and its receptor, the G protein-coupled receptor Y2. The company's headquarters are located in Lidingoe, near Stockholm. Larkberget is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Larkberget stock

P/B (Price-to-Book Ratio) of Larkberget is 0.88 in 2025.

P/B (Price-to-Book Ratio) of Larkberget changed from 0.68 to 0.88, representing a 28.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Larkberget since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Larkberget with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Larkberget

All Key Metrics — Larkberget